Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Solid Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT05013554
What this trial is testing

Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors

Who this might be right for
Neoplasm MalignantBreast CancerLung Neoplasm Malignant+2 more
Sanofi 44
Early research (Phase 1)Study completedNCT04349969
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK117 as Monotherapy or in Combination With AK104

Who this might be right for
Neoplasms Malignant
Akesobio Australia Pty Ltd 38
Testing effectiveness (Phase 2)Looking for participantsNCT07287995
What this trial is testing

ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Malignant Solid Tumors
Astellas Pharma Global Development, Inc. 428
Testing effectiveness (Phase 2)Active Not RecruitingNCT04407247
What this trial is testing

Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma

Who this might be right for
ColitisLung Non-Small Cell CarcinomaMalignant Genitourinary System Neoplasm+2 more
M.D. Anderson Cancer Center 47
Early research (Phase 1)Ended earlyNCT02706392
What this trial is testing

Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmMetastatic Lung Non-Small Cell Carcinoma+10 more
Fred Hutchinson Cancer Center 21
Early research (Phase 1)Ended earlyNCT00404521
What this trial is testing

A Phase I Study of PM02734 in Subjects With Advanced Malignant Solid Tumors

Who this might be right for
Solid Tumors
PharmaMar 56
Testing effectiveness (Phase 2)Looking for participantsNCT06410209
What this trial is testing

A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Children's Oncology Group 190
Not applicableActive Not RecruitingNCT04960787
What this trial is testing

Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their Spouses

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm
SWOG Cancer Research Network 331
Not applicableLooking for participantsNCT07221409
What this trial is testing

Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment

Who this might be right for
Adjustment DisorderAnxiety DisorderDepression+3 more
Mayo Clinic 24
Testing effectiveness (Phase 2)Study completedNCT04233567
What this trial is testing

Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations

Who this might be right for
Advanced Malignant Solid NeoplasmCholangiocarcinomaMetastatic Malignant Solid Neoplasm+1 more
Sameek Roychowdhury 17
Not applicableStudy completedNCT02140736
What this trial is testing

Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology

Who this might be right for
Chemotherapy-induced Symptomatic AnemiaSolid TumorsMalignant Hemopathies+2 more
Hospira, now a wholly owned subsidiary of Pfizer 2,333
Early research (Phase 1)Study completedNCT02898207
What this trial is testing

Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer

Who this might be right for
Metastatic High Grade Fallopian Tube Serous AdenocarcinomaMetastatic Malignant Solid NeoplasmMetastatic Primary Peritoneal Serous Adenocarcinoma+16 more
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439175
What this trial is testing

Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 70
Not applicableNot Yet RecruitingNCT07818798
What this trial is testing

Proton and Proton-Photon Hybrid Partial Stereotactic Ablative Boost Radiotherapy (P-SABR) for Unresectable Large Tumors

Who this might be right for
Unresectable Malignant NeoplasmBulky TumorSolid Tumor
Peking University First Hospital 60
Early research (Phase 1)Study completedNCT01343498
What this trial is testing

Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors

Who this might be right for
Malignant Solid Tumour
SCRI Development Innovations, LLC 33
Testing effectiveness (Phase 2)Looking for participantsNCT06810544
What this trial is testing

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Who this might be right for
Non Small Cell Lung CancerGlioma Glioblastoma MultiformeGlioma, Malignant+4 more
Tango Therapeutics, Inc. 191
Early research (Phase 1)Study completedNCT00165802
What this trial is testing

A Phase I Open Label Study of E7974 Administered on a Day 1 of 21-Day Cycle In Patients With Advanced Solid Tumors

Who this might be right for
Cancer, Malignant Tumors
Eisai Inc. 40
Early research (Phase 1)Study completedNCT00503711
What this trial is testing

Phase I Chinese PK

Who this might be right for
Advanced Solid, Malignant Tumors
Genzyme, a Sanofi Company 36
Early research (Phase 1)Active Not RecruitingNCT04294628
What this trial is testing

Testing the Biological Effects of DS-8201a on Patients With Advanced Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRefractory Malignant Solid Neoplasm+1 more
National Cancer Institute (NCI) 62
Testing effectiveness (Phase 2)Looking for participantsNCT06600022
What this trial is testing

Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant Solid Tumours.

Who this might be right for
Advanced Malignant Solid Tumours
Sinocelltech Ltd. 441
Next Page